Highlights Penumbra, Inc.

Equities

PEN

US70975L1070

Market Closed - Nyse Other stock markets 01:30:01 26/06/2024 am IST			5-day change	1st Jan Change
172.3 ^USD	-1.22%		-2.14%	-31.51%

18/06	Transcript : Penumbra, Inc. Presents at 2024 Truist Securities MedTech Conference, Jun-18-2024 10:00 AM
06/06	Transcript : Penumbra, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-06-2024 11:20 AM

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook	08/05	MT
Earnings Flash (PEN) PENUMBRA Reports Q1 Revenue $278.7M, vs. Street Est of $274.5M	08/05	MT
Earnings Flash (PEN) PENUMBRA Reports Q1 EPS $0.41, vs. Street Est of $0.38	08/05	MT
Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024	08/05	CI
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots	23/04	CI
DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	18/04	MT
Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate	28/03	MT
North American Morning Briefing : Traders Await -2-	26/02	DJ
Penumbra Q4 Non-GAAP EPS, Revenue Increase; Shares Fall After-Hours	23/02	MT
Earnings Flash (PEN) PENUMBRA Posts Q4 Revenue $284.7M, vs. Street Est of $286.5M	23/02	MT
Earnings Flash (PEN) PENUMBRA Reports Q4 EPS $0.76, vs. Street Est of $0.70	23/02	MT
Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024	23/02	CI
Penumbra, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	23/02	CI
Penumbra, Inc. Announces First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash for Treatment of Acute Pulmonary Embolism	28/11	CI
Penumbra's Q3 Non-GAAP Earnings, Revenue Rise	03/11	MT
Earnings Flash (PEN) PENUMBRA Posts Q3 Revenue $270.9M, vs. Street Est of $265.1M	03/11	MT
Earnings Flash (PEN) PENUMBRA Reports Q3 EPS $0.67, vs. Street Est of $0.45	03/11	MT
Penumbra, Inc. Provides Earnings Guidance for the Full Year 2023	03/11	CI
Penumbra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Penumbra, Inc. : The underdog in healthcare

April 12, 2024 at 07:09 am IST